1-(4-piperidinyl)methanesulfonamide hydrochloride, 95.0%, 5g

(5-Nitrothiophen-2-yl)methanol, 97%, 250mg

(1-(Tetrahydro-2H-pyran-2-yl)-5-(trifluoromethyl)-1H-indazol-4-yl)boronic acid, 97.0%, 1g

4-(Piperidin-4-ylmethyl)pyridine dihydrochloride, 95.0%, 100mg

3-(2,4-Difluorophenyl)-1-propene, 97.0%, 2g

3,5-Thiomorpholinedione, 95%, 250mg

ETHYL 1-(2,2,2-TRIFLUOROETHYL)-1H-PYRAZOLE-4-CARBOXYLATE, 95%, 1g

3-Chloro-2-fluoroisonicotinaldehyde, 95.0%, 250mg

2-Amino-4-(3-nitrophenyl)thiazole>98.0%(GC)(T)200mg

5-Ethyl-2-methoxyaniline, 97%, 100mg

6-Bromo-4-fluoro-2-methyl-2h-indazole, 98%, 250mg

(2,6-Difluoro-3,5-dimethoxyphenyl)hydrazine hydrochloride, 97.0%, 1g

Microliter syringe GASTIGHT® series 1700 Point type 2, 50 µl, 1705 RN, 1 piece